Basic information
Biomarker: Usodeoxycholic acid
Histology type: endometrial carcinoma
Stage: early-stage EC
Cohort characteristics
Country: China
Region: Jiangsu
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
78 | discovery set | 38 | validation set | 40 |
Sample information
Description: In conclusion, we established a novel and non-invasive lipid biomarker for early-stage EC detection and these findings may provide new insight into the pathological mechanisms of EC.
Sample method: UHPLC-MS/MS
Disease information
Related information
Status: Detected and Quantified
HMDB ID: HMDB0000946
Secondary accession numbers: HMDB0015525 HMDB00946 HMDB15525
Common name: rsodeoxycholic acid
Description: Ursodeoxycholic acid, also known as ursodeoxycholate or acid deoxyursocholic, belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. Ursodeoxycholic acid is a very hydrophobic molecule, practically insoluble in water, and relatively neutral.
Chemical formula: C24H40O4
Chemical taxonomy description: Belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups.
Chemical taxonomy kingdom: Organic compounds
Chemical taxonomy super class: Lipids and lipid-like molecules
Chemical taxonomy class: Steroids and steroid derivatives
Chemical taxonomy sub class: Bile acids, alcohols and derivatives
Direct parent: Dihydroxy bile acids, alcohols and derivatives
Alternative parents: 7-alpha-hydroxysteroids 3-alpha-hydroxysteroids Secondary alcohols Cyclic alcohols and derivatives Monocarboxylic acids and derivatives Carboxylic acids Organic oxides Hydrocarbon derivatives Carbonyl compounds
Substituents: Dihydroxy bile acid, alcohol, or derivatives 3-hydroxysteroid 7-hydroxysteroid 7-alpha-hydroxysteroid 3-alpha-hydroxysteroid Hydroxysteroid Cyclic alcohol Secondary alcohol Carboxylic acid derivative Carboxylic acid Monocarboxylic acid or derivatives Organic oxide Alcohol Organic oxygen compound Carbonyl group Hydrocarbon derivative Organooxygen compound Aliphatic homopolycyclic compound
Molecular framework: Aliphatic homopolycyclic compounds
Physiological effect: bitter
Disposition: bitteOrgan substructure Adrenal Cortex (HMDB: HMDB0000946) Organ Bladder (HMDB: HMDB0000946) Intestine (HMDB: HMDB0000946) Liver (HMDB: HMDB0000946) Placenta (HMDB: HMDB0000946) Cell Fibroblasts (HMDB: HMDB0000946) Tissue Muscle tissue Skeletal Muscle (HMDB: HMDB0000946) Non-excretory biofluid Biofluid or Excreta Blood (PMID: 15185309 ) Excreta Biofluid or Excreta Urine (PMID: 2621422) Feces (PMID: 22664055 ) Cellular substructure Extracellular (HMDB: HMDB0000946)
Source Food
Associated disorders diseases: Cystic fibrosis Smith JL, Lewindon PJ, Hoskins AC, Pereira TN, Setchell KD, O'Connell NC, Shepherd RW, Ramm GA: Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. Hepatology. 2004 Jun;39(6):1673-82. [PubMed:15185309 ] Colorectal cancer Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803] Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [] Primary biliary cirrhosis Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S: Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment. J Lipid Res. 1989 Dec;30(12):1953-62. [PubMed:2621422 ]
KEGG compound ID: C07880
CPD link: https://www.genome.jp/dbget-bin/www_bget?cpd:C07880
HMDB link: https://hmdb.ca/metabolites/HMDB0000946
PubChem CID: 31401
PubChem CID link: https://pubchem.ncbi.nlm.nih.gov/compound/31401